Marta Hamilton

Effects of Smoking on the Pharmacokinetics of Erlotinib

Marta Hamilton, Julie Wolf, Jason Rusk et al. · Clinical Cancer Research · 2006 · 311 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10

Results of a Randomized Controlled Trial of Mental Illness Self-management Using Wellness Recovery Action Planning

Judith Α. Cook, Mary Ellen Copeland, Jessica A. Jonikas et al. · Schizophrenia Bulletin · 2011 · 277 citations · Full text

Medicine, Community Health, Psychiatry +17

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh et al. · Neuro-Oncology · 2010 · 230 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non–small cell lung cancer

Jianfeng Lü, Steve Eppler, J WOLF et al. · Clinical Pharmacology & Therapeutics · 2006 · 224 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao et al. · Drug Metabolism and Disposition · 2005 · 222 citations

Medicine, Pharmacokinetics, Pharmacology +14